Glycogen storage disease type I other diagnostic studies
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I other diagnostic studies On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I other diagnostic studies |
FDA on Glycogen storage disease type I other diagnostic studies |
CDC on Glycogen storage disease type I other diagnostic studies |
Glycogen storage disease type I other diagnostic studies in the news |
Blogs on Glycogen storage disease type I other diagnostic studies |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other Diagnostic Studies
The diagnosis is definitively confirmed by liver biopsy with electron microscopy and assay of glucose-6-phosphatase activity in the tissue and/or specific gene testing, available in recent years.
Prenatal diagnosis has been made by fetal liver biopsy at 18-22 weeks of gestation, but no fetal treatment has been proposed. Prenatal diagnosis is possible with fetal DNA obtained by chorionic villus sampling when a fetus is known to be at risk.